The level is in the details: Why differences between direct-acting oral anticoagulants should be considered in the treatment of patients with epilepsy

被引：0
作者：
Cohen, Hagar [1 ]
Bahash, Nahawand [1 ]
Raccah, Bruria [1 ]
Matok, Ilan [1 ]
Ekstein, Dana [2 ,3 ]
Goldstein, Lee [4 ,5 ]
Kalish, Yosef [3 ,6 ]
Eyal, Sara [1 ]
机构：
[1] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Dept Clin Pharm, IL-91120 Jerusalem, Israel
[2] Hadassah Med Org, Agnes Ginges Ctr Human Neurogenet, Dept Neurol, Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
[4] Haemek Med Ctr, Internal Med & Clin Pharmacol Unit C, Afula, Israel
[5] Technion, Bruce Rapapport Sch Med, H_efa, Israel
[6] Hebrew Univ Jerusalem, Hadassah Med Fac Med, Dept Hematol, Jerusalem, Israel
来源：
EPILEPSIA | 2024年 / 65卷 / 12期
关键词：
antiepileptic drugs; AUC; drug interactions; edoxaban; pregnane xenobiotic receptor; DRUG-DRUG INTERACTIONS; VALPROIC ACID; P-GLYCOPROTEIN; IN-VITRO; ESLICARBAZEPINE ACETATE; ETHINYL ESTRADIOL; PHARMACOKINETICS; METABOLISM; INDUCTION; DABIGATRAN;
D O I：
10.1111/epi.18144
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：3474 / 3483
页数：10
相关论文
共 75 条
  • [1] Levetiracetam Interaction with Direct Oral Anticoagulants: A Pharmacovigilance Study
    Abou Kaoud, Mohammed
    Nissan, Ran
    Segev, Amitai
    Sabbag, Avi
    Orion, David
    Maor, Elad
    [J]. CNS DRUGS, 2023, 37 (12) : 1111 - 1121
  • [2] Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events
    Acton, Emily K.
    Hennessy, Sean
    Gelfand, Michael A.
    Leonard, Charles E.
    Bilker, Warren B.
    Shu, Di
    Willis, Allison W.
    Kasner, Scott E.
    [J]. JAMA NEUROLOGY, 2024, 81 (08) : 835 - 844
  • [3] A mechanistic approach to antiepileptic drug interactions
    Anderson, GD
    [J]. ANNALS OF PHARMACOTHERAPY, 1998, 32 (05) : 554 - 563
  • [4] [Anonymous], 2010, FWSN Process and Outcome Evaluation
  • [5] Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants
    Bansal, Sumit
    Zamarripa, C. Austin
    Spindle, Tory R.
    Weerts, Elise M.
    Thummel, Kenneth E.
    Vandrey, Ryan
    Paine, Mary F.
    Unadkat, Jashvant D.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (03) : 693 - 703
  • [6] The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans
    Blech, Stefan
    Ebner, Thomas
    Ludwig-Schwellinger, Eva
    Stangier, Joachim
    Roth, Willy
    [J]. DRUG METABOLISM AND DISPOSITION, 2008, 36 (02) : 386 - 399
  • [7] Drug interaction profile of topiramate
    Bourgeois, BFD
    [J]. EPILEPSIA, 1996, 37 : S14 - S17
  • [8] Enzyme induction with antiepileptic drugs: Cause for concern?
    Brodie, Martin J.
    Mintzer, Scott
    Pack, Alison M.
    Gidal, Barry E.
    Vecht, Charles J.
    Schmidt, Dieter
    [J]. EPILEPSIA, 2013, 54 (01) : 11 - 27
  • [9] Effect of Lacosamide on the Steady-State Pharmacokinetics of Digoxin: Results from a Phase I, Multiple-Dose, Double-Blind, Randomised, Placebo-Controlled, Crossover Trial
    Cawello, Willi
    Mueller-Voessing, Christa
    Andreas, Jens-Otto
    [J]. CLINICAL DRUG INVESTIGATION, 2014, 34 (05) : 327 - 334
  • [10] Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human
    Cazali, N
    Tran, A
    Treluyer, JM
    Rey, E
    d'Athis, P
    Vincent, J
    Pons, G
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (05) : 526 - 536
12345678